Table of Content

1 Biosimilars Market Overview
1.1 Biosimilars Product Overview
1.2 Biosimilars Market Segment by Type
1.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.2 Recombinant Glycosylated Proteins
1.3 Global Biosimilars Market Size by Type
1.3.1 Global Biosimilars Market Size Overview by Type (2018-2034)
1.3.2 Global Biosimilars Historic Market Size Review by Type (2018-2024)
1.3.3 Global Biosimilars Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biosimilars Sales Breakdown by Type (2018-2024)
1.4.2 Europe Biosimilars Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Biosimilars Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Biosimilars Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Biosimilars Sales Breakdown by Type (2018-2024)
2 Global Biosimilars Market Competition by Company
2.1 Global Top Players by Biosimilars Sales (2018-2024)
2.2 Global Top Players by Biosimilars Revenue (2018-2024)
2.3 Global Top Players by Biosimilars Price (2018-2024)
2.4 Global Top Manufacturers Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Biosimilars Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars as of 2022)
2.7 Date of Key Manufacturers Enter into Biosimilars Market
2.8 Key Manufacturers Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biosimilars Status and Outlook by Region
3.1 Global Biosimilars Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Biosimilars Historic Market Size by Region
3.2.1 Global Biosimilars Sales in Volume by Region (2018-2024)
3.2.2 Global Biosimilars Sales in Value by Region (2018-2024)
3.2.3 Global Biosimilars Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Biosimilars Forecasted Market Size by Region
3.3.1 Global Biosimilars Sales in Volume by Region (2024-2034)
3.3.2 Global Biosimilars Sales in Value by Region (2024-2034)
3.3.3 Global Biosimilars Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Biosimilars by Application
4.1 Biosimilars Market Segment by Application
4.1.1 Oncology
4.1.2 Blood Disorders
4.1.3 Growth Hormonal Deficiency
4.1.4 Chronic and Autoimmune Disorders
4.1.5 Others
4.2 Global Biosimilars Market Size by Application
4.2.1 Global Biosimilars Market Size Overview by Application (2018-2034)
4.2.2 Global Biosimilars Historic Market Size Review by Application (2018-2024)
4.2.3 Global Biosimilars Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biosimilars Sales Breakdown by Application (2018-2024)
4.3.2 Europe Biosimilars Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Biosimilars Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Biosimilars Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Biosimilars Sales Breakdown by Application (2018-2024)
5 North America Biosimilars by Country
5.1 North America Biosimilars Historic Market Size by Country
5.1.1 North America Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Biosimilars Sales in Volume by Country (2018-2024)
5.1.3 North America Biosimilars Sales in Value by Country (2018-2024)
5.2 North America Biosimilars Forecasted Market Size by Country
5.2.1 North America Biosimilars Sales in Volume by Country (2024-2034)
5.2.2 North America Biosimilars Sales in Value by Country (2024-2034)
6 Europe Biosimilars by Country
6.1 Europe Biosimilars Historic Market Size by Country
6.1.1 Europe Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Biosimilars Sales in Volume by Country (2018-2024)
6.1.3 Europe Biosimilars Sales in Value by Country (2018-2024)
6.2 Europe Biosimilars Forecasted Market Size by Country
6.2.1 Europe Biosimilars Sales in Volume by Country (2024-2034)
6.2.2 Europe Biosimilars Sales in Value by Country (2024-2034)
7 Asia-Pacific Biosimilars by Region
7.1 Asia-Pacific Biosimilars Historic Market Size by Region
7.1.1 Asia-Pacific Biosimilars Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Biosimilars Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Biosimilars Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Biosimilars Forecasted Market Size by Region
7.2.1 Asia-Pacific Biosimilars Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Biosimilars Sales in Value by Region (2024-2034)
8 Latin America Biosimilars by Country
8.1 Latin America Biosimilars Historic Market Size by Country
8.1.1 Latin America Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Biosimilars Sales in Volume by Country (2018-2024)
8.1.3 Latin America Biosimilars Sales in Value by Country (2018-2024)
8.2 Latin America Biosimilars Forecasted Market Size by Country
8.2.1 Latin America Biosimilars Sales in Volume by Country (2024-2034)
8.2.2 Latin America Biosimilars Sales in Value by Country (2024-2034)
9 Middle East and Africa Biosimilars by Country
9.1 Middle East and Africa Biosimilars Historic Market Size by Country
9.1.1 Middle East and Africa Biosimilars Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Biosimilars Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Biosimilars Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Biosimilars Forecasted Market Size by Country
9.2.1 Middle East and Africa Biosimilars Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Biosimilars Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Biosimilars Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis Biosimilars Products Offered
10.2.5 Novartis Recent Development
10.3 Biocon
10.3.1 Biocon Company Information
10.3.2 Biocon Introduction and Business Overview
10.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biocon Biosimilars Products Offered
10.3.5 Biocon Recent Development
10.4 Biogen
10.4.1 Biogen Company Information
10.4.2 Biogen Introduction and Business Overview
10.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biogen Biosimilars Products Offered
10.4.5 Biogen Recent Development
10.5 Fresenius Kabi AG
10.5.1 Fresenius Kabi AG Company Information
10.5.2 Fresenius Kabi AG Introduction and Business Overview
10.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Fresenius Kabi AG Biosimilars Products Offered
10.5.5 Fresenius Kabi AG Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Boehringer Ingelheim Biosimilars Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Merck KgaA
10.7.1 Merck KgaA Company Information
10.7.2 Merck KgaA Introduction and Business Overview
10.7.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck KgaA Biosimilars Products Offered
10.7.5 Merck KgaA Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mylan Biosimilars Products Offered
10.8.5 Mylan Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly Biosimilars Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Teva Pharmaceutical
10.10.1 Teva Pharmaceutical Company Information
10.10.2 Teva Pharmaceutical Introduction and Business Overview
10.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Teva Pharmaceutical Biosimilars Products Offered
10.10.5 Teva Pharmaceutical Recent Development
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Company Information
10.11.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Dr. Reddy's Laboratories Biosimilars Products Offered
10.11.5 Dr. Reddy's Laboratories Recent Development
10.12 Amgen
10.12.1 Amgen Company Information
10.12.2 Amgen Introduction and Business Overview
10.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Amgen Biosimilars Products Offered
10.12.5 Amgen Recent Development
10.13 Celltrion
10.13.1 Celltrion Company Information
10.13.2 Celltrion Introduction and Business Overview
10.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Celltrion Biosimilars Products Offered
10.13.5 Celltrion Recent Development
10.14 Samsung Biologics
10.14.1 Samsung Biologics Company Information
10.14.2 Samsung Biologics Introduction and Business Overview
10.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Samsung Biologics Biosimilars Products Offered
10.14.5 Samsung Biologics Recent Development
10.15 Roche
10.15.1 Roche Company Information
10.15.2 Roche Introduction and Business Overview
10.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Roche Biosimilars Products Offered
10.15.5 Roche Recent Development
10.16 Probiomed
10.16.1 Probiomed Company Information
10.16.2 Probiomed Introduction and Business Overview
10.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Probiomed Biosimilars Products Offered
10.16.5 Probiomed Recent Development
10.17 Apotex
10.17.1 Apotex Company Information
10.17.2 Apotex Introduction and Business Overview
10.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Apotex Biosimilars Products Offered
10.17.5 Apotex Recent Development
10.18 Chong Kun Dang
10.18.1 Chong Kun Dang Company Information
10.18.2 Chong Kun Dang Introduction and Business Overview
10.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Chong Kun Dang Biosimilars Products Offered
10.18.5 Chong Kun Dang Recent Development
10.19 JCR Pharmaceuticals
10.19.1 JCR Pharmaceuticals Company Information
10.19.2 JCR Pharmaceuticals Introduction and Business Overview
10.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.19.4 JCR Pharmaceuticals Biosimilars Products Offered
10.19.5 JCR Pharmaceuticals Recent Development
10.20 Gan & Lee Pharmaceuticals
10.20.1 Gan & Lee Pharmaceuticals Company Information
10.20.2 Gan & Lee Pharmaceuticals Introduction and Business Overview
10.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Gan & Lee Pharmaceuticals Biosimilars Products Offered
10.20.5 Gan & Lee Pharmaceuticals Recent Development
10.21 Gedeon Richter
10.21.1 Gedeon Richter Company Information
10.21.2 Gedeon Richter Introduction and Business Overview
10.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Gedeon Richter Biosimilars Products Offered
10.21.5 Gedeon Richter Recent Development
10.22 Biocad
10.22.1 Biocad Company Information
10.22.2 Biocad Introduction and Business Overview
10.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Biocad Biosimilars Products Offered
10.22.5 Biocad Recent Development
10.23 Coherus Bioscience
10.23.1 Coherus Bioscience Company Information
10.23.2 Coherus Bioscience Introduction and Business Overview
10.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Coherus Bioscience Biosimilars Products Offered
10.23.5 Coherus Bioscience Recent Development
10.24 Stada Arzneimittel AG
10.24.1 Stada Arzneimittel AG Company Information
10.24.2 Stada Arzneimittel AG Introduction and Business Overview
10.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Stada Arzneimittel AG Biosimilars Products Offered
10.24.5 Stada Arzneimittel AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biosimilars Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biosimilars Industrial Chain Analysis
11.4 Biosimilars Market Dynamics
11.4.1 Biosimilars Industry Trends
11.4.2 Biosimilars Market Drivers
11.4.3 Biosimilars Market Challenges
11.4.4 Biosimilars Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biosimilars Distributors
12.3 Biosimilars Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 2. Major Company of Recombinant Glycosylated Proteins
Table 3. Global Biosimilars Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Biosimilars Sales by Type (2018-2024) & (K Units)
Table 5. Global Biosimilars Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Biosimilars Sales by Type (2018-2024) & (US& Million)
Table 7. Global Biosimilars Market Share in Value by Type (2018-2024)
Table 8. Global Biosimilars Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Biosimilars Sales by Type (2024-2034) & (K Units)
Table 10. Global Biosimilars Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Biosimilars Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Biosimilars Sales Market Share in Value by Type (2024-2034)
Table 13. Global Biosimilars Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Biosimilars Sales by Type (2018-2024) & (K Units)
Table 15. North America Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Biosimilars Sales (K Units) by Type (2018-2024)
Table 17. Europe Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Biosimilars Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Biosimilars Sales (K Units) by Type (2018-2024)
Table 21. Latin America Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Biosimilars Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Biosimilars Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Biosimilars Sales by Company (2018-2024) & (K Units)
Table 25. Global Biosimilars Sales Share by Company (2018-2024)
Table 26. Global Biosimilars Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Biosimilars Revenue Share by Company (2018-2024)
Table 28. Global Market Biosimilars Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Biosimilars Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars as of 2022)
Table 32. Date of Key Manufacturers Enter into Biosimilars Market
Table 33. Key Manufacturers Biosimilars Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Biosimilars Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Biosimilars Sales by Region (2018-2024) & (K Units)
Table 37. Global Biosimilars Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Biosimilars Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Biosimilars Sales Market Share in Value by Region (2018-2024)
Table 40. Global Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Biosimilars Sales by Region (2024-2034) & (K Units)
Table 42. Global Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 45. Global Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Biosimilars Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Biosimilars Sales by Application (2018-2024) & (K Units)
Table 48. Global Biosimilars Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Biosimilars Sales Market Share in Value by Application (2018-2024)
Table 51. Global Biosimilars Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Biosimilars Sales by Application (2024-2034) & (K Units)
Table 53. Global Biosimilars Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Biosimilars Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Biosimilars Sales Market Share in Value by Application (2024-2034)
Table 56. Global Biosimilars Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Biosimilars Sales by Application (2018-2024) (K Units)
Table 58. North America Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Biosimilars Sales by Application (2018-2024) (K Units)
Table 60. Europe Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Biosimilars Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Biosimilars Sales by Application (2018-2024) (K Units)
Table 64. Latin America Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Biosimilars Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Biosimilars Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Biosimilars Sales by Country (2018-2024) & (K Units)
Table 68. North America Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 71. North America Biosimilars Sales by Country (2024-2034) & (K Units)
Table 72. North America Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Biosimilars Sales by Country (2018-2024) & (K Units)
Table 76. Europe Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Biosimilars Sales by Country (2024-2034) & (K Units)
Table 80. Europe Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Biosimilars Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Biosimilars Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Biosimilars Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Biosimilars Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Biosimilars Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Biosimilars Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Biosimilars Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Biosimilars Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Biosimilars Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Biosimilars Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Biosimilars Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Biosimilars Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Biosimilars Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Biosimilars Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Biosimilars Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Biosimilars Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Biosimilars Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Biosimilars Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Biosimilars Product
Table 111. Pfizer Recent Development
Table 112. Novartis Company Information
Table 113. Novartis Introduction and Business Overview
Table 114. Novartis Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Novartis Biosimilars Product
Table 116. Novartis Recent Development
Table 117. Biocon Company Information
Table 118. Biocon Introduction and Business Overview
Table 119. Biocon Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Biocon Biosimilars Product
Table 121. Biocon Recent Development
Table 122. Biogen Company Information
Table 123. Biogen Introduction and Business Overview
Table 124. Biogen Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Biogen Biosimilars Product
Table 126. Biogen Recent Development
Table 127. Fresenius Kabi AG Company Information
Table 128. Fresenius Kabi AG Introduction and Business Overview
Table 129. Fresenius Kabi AG Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Fresenius Kabi AG Biosimilars Product
Table 131. Fresenius Kabi AG Recent Development
Table 132. Boehringer Ingelheim Company Information
Table 133. Boehringer Ingelheim Introduction and Business Overview
Table 134. Boehringer Ingelheim Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Boehringer Ingelheim Biosimilars Product
Table 136. Boehringer Ingelheim Recent Development
Table 137. Merck KgaA Company Information
Table 138. Merck KgaA Introduction and Business Overview
Table 139. Merck KgaA Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Merck KgaA Biosimilars Product
Table 141. Merck KgaA Recent Development
Table 142. Mylan Company Information
Table 143. Mylan Introduction and Business Overview
Table 144. Mylan Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Mylan Biosimilars Product
Table 146. Mylan Recent Development
Table 147. Eli Lilly Company Information
Table 148. Eli Lilly Introduction and Business Overview
Table 149. Eli Lilly Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Eli Lilly Biosimilars Product
Table 151. Eli Lilly Recent Development
Table 152. Teva Pharmaceutical Company Information
Table 153. Teva Pharmaceutical Introduction and Business Overview
Table 154. Teva Pharmaceutical Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Teva Pharmaceutical Biosimilars Product
Table 156. Teva Pharmaceutical Recent Development
Table 157. Dr. Reddy's Laboratories Company Information
Table 158. Dr. Reddy's Laboratories Introduction and Business Overview
Table 159. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Dr. Reddy's Laboratories Biosimilars Product
Table 161. Dr. Reddy's Laboratories Recent Development
Table 162. Amgen Company Information
Table 163. Amgen Introduction and Business Overview
Table 164. Amgen Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Amgen Biosimilars Product
Table 166. Amgen Recent Development
Table 167. Celltrion Company Information
Table 168. Celltrion Introduction and Business Overview
Table 169. Celltrion Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Celltrion Biosimilars Product
Table 171. Celltrion Recent Development
Table 172. Samsung Biologics Company Information
Table 173. Samsung Biologics Introduction and Business Overview
Table 174. Samsung Biologics Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 175. Samsung Biologics Biosimilars Product
Table 176. Samsung Biologics Recent Development
Table 177. Roche Company Information
Table 178. Roche Introduction and Business Overview
Table 179. Roche Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 180. Roche Biosimilars Product
Table 181. Roche Recent Development
Table 182. Probiomed Company Information
Table 183. Probiomed Introduction and Business Overview
Table 184. Probiomed Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 185. Probiomed Biosimilars Product
Table 186. Probiomed Recent Development
Table 187. Apotex Company Information
Table 188. Apotex Introduction and Business Overview
Table 189. Apotex Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 190. Apotex Biosimilars Product
Table 191. Apotex Recent Development
Table 192. Chong Kun Dang Company Information
Table 193. Chong Kun Dang Introduction and Business Overview
Table 194. Chong Kun Dang Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 195. Chong Kun Dang Biosimilars Product
Table 196. Chong Kun Dang Recent Development
Table 197. JCR Pharmaceuticals Company Information
Table 198. JCR Pharmaceuticals Introduction and Business Overview
Table 199. JCR Pharmaceuticals Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 200. JCR Pharmaceuticals Biosimilars Product
Table 201. JCR Pharmaceuticals Recent Development
Table 202. Gan & Lee Pharmaceuticals Company Information
Table 203. Gan & Lee Pharmaceuticals Introduction and Business Overview
Table 204. Gan & Lee Pharmaceuticals Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 205. Gan & Lee Pharmaceuticals Biosimilars Product
Table 206. Gan & Lee Pharmaceuticals Recent Development
Table 207. Gedeon Richter Company Information
Table 208. Gedeon Richter Introduction and Business Overview
Table 209. Gedeon Richter Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 210. Gedeon Richter Biosimilars Product
Table 211. Gedeon Richter Recent Development
Table 212. Biocad Company Information
Table 213. Biocad Introduction and Business Overview
Table 214. Biocad Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 215. Biocad Biosimilars Product
Table 216. Biocad Recent Development
Table 217. Coherus Bioscience Company Information
Table 218. Coherus Bioscience Introduction and Business Overview
Table 219. Coherus Bioscience Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 220. Coherus Bioscience Biosimilars Product
Table 221. Coherus Bioscience Recent Development
Table 222. Stada Arzneimittel AG Company Information
Table 223. Stada Arzneimittel AG Introduction and Business Overview
Table 224. Stada Arzneimittel AG Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 225. Stada Arzneimittel AG Biosimilars Product
Table 226. Stada Arzneimittel AG Recent Development
Table 227. Key Raw Materials Lists
Table 228. Raw Materials Key Suppliers Lists
Table 229. Biosimilars Market Trends
Table 230. Biosimilars Market Drivers
Table 231. Biosimilars Market Challenges
Table 232. Biosimilars Market Restraints
Table 233. Biosimilars Distributors List
Table 234. Biosimilars Downstream Customers
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars Product Picture
Figure 2. Global Biosimilars Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biosimilars Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Biosimilars Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure 6. Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Recombinant Glycosylated Proteins
Figure 8. Global Recombinant Glycosylated Proteins Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Biosimilars Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Biosimilars Sales Market Share by Type in 2022 & 2034
Figure 11. North America Biosimilars Sales Market Share in Volume by Type in 2022
Figure 12. North America Biosimilars Sales Market Share in Value by Type in 2022
Figure 13. Europe Biosimilars Sales Market Share in Volume by Type in 2022
Figure 14. Europe Biosimilars Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Biosimilars Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Biosimilars Sales Market Share in Value by Type in 2022
Figure 17. Latin America Biosimilars Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Biosimilars Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Biosimilars Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Biosimilars Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilars Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilars Revenue in 2022
Figure 23. Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Oncology
Figure 25. Global Oncology Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Blood Disorders
Figure 27. Global Blood Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Growth Hormonal Deficiency
Figure 29. Global Growth Hormonal Deficiency Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Chronic and Autoimmune Disorders
Figure 31. Global Chronic and Autoimmune Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Biosimilars Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Biosimilars Sales Market Share by Application in 2022 & 2034
Figure 36. North America Biosimilars Sales Market Share in Volume by Application in 2022
Figure 37. North America Biosimilars Sales Market Share in Value by Application in 2022
Figure 38. Europe Biosimilars Sales Market Share in Volume by Application in 2022
Figure 39. Europe Biosimilars Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Biosimilars Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Biosimilars Sales Market Share in Value by Application in 2022
Figure 42. Latin America Biosimilars Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Biosimilars Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Biosimilars Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Biosimilars Manufacturing Cost Structure
Figure 47. Biosimilars Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed